STESTERIS plc

NYSE steris.com


$ 201.54 $ -1.26 (-0.62 %)    

Thursday, 25-Apr-2024 15:59:59 EDT
QQQ $ 430.17 $ 9.15 (2.17 %)
DIA $ 380.88 $ -3.52 (-0.92 %)
SPY $ 507.81 $ 5.55 (1.11 %)
TLT $ 87.78 $ -0.61 (-0.69 %)
GLD $ 215.92 $ 1.28 (0.6 %)
$ 201.54
$ 203.25
$ 0.00 x 0
$ 0.00 x 0
$ 200.51 - $ 203.25
$ 178.86 - $ 252.21
492,086
na
20.04B
$ 0.95
$ 35.35
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 02-08-2024 12-31-2023 10-Q
2 11-07-2023 09-30-2023 10-Q
3 08-08-2023 06-30-2023 10-Q
4 05-26-2023 03-31-2023 10-K
5 02-08-2023 12-31-2022 10-Q
6 11-09-2022 09-30-2022 10-Q
7 08-08-2022 06-30-2022 10-Q
8 05-31-2022 03-31-2022 10-K
9 02-09-2022 12-31-2021 10-Q
10 11-08-2021 09-30-2021 10-Q
11 08-09-2021 06-30-2021 10-Q
12 05-28-2021 03-31-2021 10-K
13 02-09-2021 12-31-2020 10-Q
14 11-06-2020 09-30-2020 10-Q
15 08-07-2020 06-30-2020 10-Q
16 05-29-2020 03-31-2020 10-K
17 02-10-2020 12-31-2019 10-Q
18 11-07-2019 09-30-2019 10-Q
19 08-07-2019 06-30-2019 10-Q
20 05-30-2019 03-31-2019 10-K
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 needham-reiterates-hold-on-steris
Needham Reiterates Hold on Steris
04/12/2024 08:39:39

Needham analyst Mike Matson reiterates Steris (NYSE:STE) with a Hold.

 steris-enters-definitive-deal-to-divest-its-dental-segment-to-peak-rock-capital-for-7875m

The Transaction is structured as an equity sale. The Transaction terms also include the opportunity for STERIS to receive an ad...

 stephens--co-reiterates-overweight-on-steris-maintains-250-price-target

Stephens & Co. analyst Jacob Johnson reiterates Steris (NYSE:STE) with a Overweight and maintains $250 price target.

 jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

 recap-steris-q3-earnings
Recap: Steris Q3 Earnings
02/07/2024 21:40:23

 steris-now-expects-fy24-as-reported-revenue-to-increase-10-11-up-from-previous-expectations-of-9-10-revises-adjusted-eps-outlook-from-860-880-to-860-870-est-867

Adjusted earnings per diluted share revised due primarily to a shift in operating income mix from AST to Healthcare.  

 steris-q3-adj-eps-222-beats-217-estimate

Steris (NYSE:STE) reported quarterly Adj earnings of $2.22 per share which beat the analyst consensus estimate of $2.17 by 2.3 ...

 earnings-scheduled-for-february-7-2024

Companies Reporting Before The Bell • Madison Square Garden (NYSE:MSGE) is expected to report quarterly loss at $0.80 per shar...

 earnings-outlook-for-steris
Earnings Outlook For Steris
02/06/2024 18:02:08

 keybanc-initiates-coverage-on-steris-with-overweight-rating-announces-price-target-of-253

Keybanc analyst Brett Fishbin initiates coverage on Steris (NYSE:STE) with a Overweight rating and announces Price Target of...

Core News & Articles

At the end of today, December 21, 2023, Steris (NYSE:STE) will distribute a dividend payout of $0.52 per share, translating to ...

 morgan-stanley-maintains-equal-weight-on-steris-lowers-price-target-to-215

Morgan Stanley analyst Patrick Wood maintains Steris (NYSE:STE) with a Equal-Weight and lowers the price target from $225 to...

 jmp-securities-reiterates-market-outperform-on-steris-maintains-265-price-target

JMP Securities analyst David Turkaly reiterates Steris (NYSE:STE) with a Market Outperform and maintains $265 price target.

 steris-sees-fy24-eps-860-880-vs-875-est-revenue-growth-of-9-10

Fiscal 2024 OutlookThe company is confirming its outlook for fiscal 2024 of as reported revenue growth of 9-10% and constant cu...

 recap-steris-q2-earnings
Recap: Steris Q2 Earnings
11/07/2023 21:40:31

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION